MIGDAL HA'EMEQ, Israel, Dec. 2, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that Dr. Ariel Katz, the Company's President and Chief Executive Officer, will be presenting at the Wedbush Securities California Dreamin' Consumer Conference: The New York Edition to be held on Tuesday, December 10, 2013 in New York, NY.
Enzymotec's presentation is scheduled for Tuesday, December 10, at 10:20 am ET.
The audio portion of the presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at www.enzymotec.com.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-functional lipid ingredients, as well as final products, based on sophisticated processes and technologies.